GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Fortis Healthcare Ltd

Fortis Healthcare Board to meet November 5, 2026, for Q2 FY27 Results

RESULTS ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 29 Oct 2026, 04:22 PM IST  ·  BSE ID: 00d666ab-acff-4923-8db3-78aa42b54408
View Original BSE Filing (PDF)
💡
In Simple Terms
Fortis Healthcare's board will meet on November 5, 2026, to review financial results and discuss changes to its debentures.
🤖 AI Summary
  • Fortis Healthcare Board meeting scheduled for Thursday, November 5, 2026.
  • Consideration and approval of unaudited Q2 FY27 financial results (standalone & consolidated) for quarter/half year ended September 30, 2026.
  • Discussion on altering rights and terms of 1,55,000 listed Non-Convertible Debentures.
  • Aggregate value of debentures up to INR 1550,00,00,000/- to be discussed.
  • Trading window closed until November 7, 2026, post financial results declaration.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Number of Listed Non-Convertible Debentures
1,55,000
Face Value per Debenture
INR 1,00,000/-
Aggregate Value of Debentures
INR 1550,00,00,000/-
🏢 How This Affects the Company
💰
Financial Impact
The Board will consider changes to the terms of existing Non-Convertible Debentures with an aggregate value of up to INR 1550,00,00,000/-, which could affect the company's financing structure.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this prior intimation.
👤
Who Is Affected
Shareholders will be affected by the financial results to be approved for the quarter and half year ended September 30, 2026. Debenture holders will be directly affected by any alteration to rights and terms of the 1,55,000 listed Non-Convertible Debentures.
🔍
Management Signal
The management is adhering to regulatory disclosure requirements by intimating the Board meeting for financial results and debenture term alterations.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board Meeting Outcome on November 5, 2026 — details of Q2 FY27 results
Details of debenture rights alteration — check terms for INR 1550,00,00,000/- debentures
Confirmation of trading window re-opening on November 7, 2026
LOW RISK This is a routine intimation of a board meeting; no immediate new risks are evident.
💡 Investor Takeaway
Fortis Healthcare's Board will meet on November 5, 2026, to consider Q2 FY27 unaudited financial results and potential alteration of rights for 1,55,000 Non-Convertible Debentures with an aggregate value up to INR 1550,00,00,000/-.
📅 Company Track Record
Fortis Healthcare previously informed BSE on July 30, 2026, about a Board meeting held on August 06, 2026, to consider Q1 FY27 unaudited financial results. This current filing maintains the regular quarterly reporting cycle.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is Fortis Healthcare's next Board meeting scheduled?
Fortis Healthcare's Board of Directors meeting is scheduled for Thursday, November 5, 2026.
What financial results will be considered at the Fortis Healthcare Board meeting?
The Board will consider and approve the un-audited financial results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026.
What is the total value of debentures to be discussed by Fortis Healthcare's Board?
The Board will discuss alterations for 1,55,000 listed Non-Convertible Debentures with an aggregate value of up to INR 1550,00,00,000/-.
When will the trading window for Fortis Healthcare securities re-open?
The trading window for Fortis Healthcare securities will remain closed until 48 hours from the declaration of Un-audited Financial Results, i.e., upto November 07, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.